{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:21:35Z","timestamp":1793402495770,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The World Health Organization recommends the use of isoniazid (INH) alone or in combination with rifapentine to treat latent tuberculosis infections. The recent rise of drug-resistant tuberculosis has complicated the choice of treatment regimen for latent tuberculosis infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the effects of INH preventive therapy on the contacts of patients with multidrug-resistant tuberculosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a prospective cohort study conducted between September 2009 and August 2012, we identified 4,500 index patients with tuberculosis and 14,044 tuberculosis-exposed household contacts who we followed for 1 year for the occurrence of incident tuberculosis disease. Although Peruvian national guidelines specify that INH preventive therapy should be provided to contacts aged 19 years old or younger, only half this group received INH preventive therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Among 4,216 contacts under 19 years of age, 2,106 contacts (50%) initiated INH preventive therapy at enrollment. The protective effect of INH was more extreme in contacts exposed to drug-sensitive tuberculosis (adjusted hazard ratio, 0.30; 95% confidence interval, 0.18\u20130.48) and to multidrug-resistant tuberculosis (adjusted hazard ratio, 0.19; 95% confidence interval, 0.05\u20130.66) compared with those exposed to mono\u2013INH-resistant tuberculosis (adjusted hazard ratio, 0.80; 95% confidence interval, 0.23\u20132.80). In the second independent study, tuberculosis occurred in none of the 76 household contacts who received INH preventive therapy compared with 3% (8 of 273) of those who did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Household contacts who received INH preventive therapy had a lower incidence of tuberculosis disease even when they had been exposed to an index patient with multidrug-resistant tuberculosis. INH may have a role in the management of latent multidrug-resistant tuberculosis infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201908-1576oc","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T17:30:11Z","timestamp":1592415011000},"page":"1159-1168","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":40,"title":["Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis"],"prefix":"10.1093","volume":"202","author":[{"given":"Chuan-Chin","family":"Huang","sequence":"first","affiliation":[{"name":"Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes C.","family":"Becerra","sequence":"additional","affiliation":[{"name":"Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Calderon","sequence":"additional","affiliation":[{"name":"Partners in Health\u2014Socios En Salud Sucursal, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Contreras","sequence":"additional","affiliation":[{"name":"Partners in Health\u2014Socios En Salud Sucursal, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Galea","sequence":"additional","affiliation":[{"name":"School of Social Work, University of South Florida, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Grandjean","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Clinical Tropical Medicine, Imperial College London, London, United Kingdom"},{"name":"Universidad Peruana Cayetano Heredia, Lima, Peru; and"},{"name":"TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Lecca","sequence":"additional","affiliation":[{"name":"Partners in Health\u2014Socios En Salud Sucursal, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Yataco","sequence":"additional","affiliation":[{"name":"Partners in Health\u2014Socios En Salud Sucursal, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-1986","authenticated-orcid":false,"given":"Megan","family":"Murray","sequence":"additional","affiliation":[{"name":"Division of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2026030321502231900_bib1","article-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2019"},{"key":"2026030321502231900_bib2","article-title":"Latent tuberculosis infection, updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"key":"2026030321502231900_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","article-title":"Preventive therapy for latent tuberculosis infection-the promise and the challenges","volume":"56","author":"Fox","year":"2017","journal-title":"Int J Infect Dis"},{"key":"2026030321502231900_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cid\/cis920","article-title":"Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa","volume":"56","author":"Jacobson","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026030321502231900_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"key":"2026030321502231900_bib6","article-title":"Isoniazid preventive therapy protects against tuberculosis among household contacts of isoniazid-resistant patients [preprint]","author":"Huang","year":"2018","journal-title":"bioRxiv"},{"key":"2026030321502231900_bib7","article-title":"Norma t\u00e9cnica de salud para el control de la tuberculosis","author":"Ministerio de Salud","year":"2006"},{"key":"2026030321502231900_bib8","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1093\/infdis\/jis008","article-title":"Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease: consensus from an expert panel","volume":"205","author":"Graham","year":"2012","journal-title":"J Infect Dis"},{"key":"2026030321502231900_bib9","doi-asserted-by":"crossref","first-page":"l5894","DOI":"10.1136\/bmj.l5894","article-title":"Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study","volume":"24","author":"Becerra","year":"2019","journal-title":"BMJ"},{"key":"2026030321502231900_bib10","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/sim.1259","article-title":"Proportional hazards models with frailties and random effects","volume":"21","author":"O\u2019Quigley","year":"2002","journal-title":"Stat Med"},{"key":"2026030321502231900_bib11","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the UAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"key":"2026030321502231900_bib12","author":"R Core Team","year":"2017","journal-title":"R: A language and environment for statistical computing."},{"key":"2026030321502231900_bib13","doi-asserted-by":"crossref","first-page":"e1001843","DOI":"10.1371\/journal.pmed.1001843","article-title":"Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: a prospective cohort study","volume":"12","author":"Grandjean","year":"2015","journal-title":"PLoS Med"},{"key":"2026030321502231900_bib14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/JCM.38.3.1203-1208.2000","article-title":"Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures: the Tuberculosis Working Group in Peru","volume":"38","author":"Caviedes","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2026030321502231900_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","author":"Kritski","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321502231900_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/thx.2008.100974","article-title":"Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort","volume":"64","author":"Attamna","year":"2009","journal-title":"Thorax"},{"key":"2026030321502231900_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"2026030321502231900_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.5588\/ijtld.13.0872","article-title":"Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation","volume":"18","author":"Garcia-Prats","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321502231900_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.5588\/ijtld.12.0092","article-title":"Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995 -2010","volume":"16","author":"Denholm","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321502231900_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1017\/S0950268817003120","article-title":"Implications of a school outbreak of multidrug-resistant tuberculosis in Northern China","volume":"145","author":"Wu","year":"2018","journal-title":"Epidemiol Infect"},{"key":"2026030321502231900_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study","volume":"57","author":"Seddon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026030321502231900_bib22","first-page":"326","article-title":"Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008","volume":"15","author":"Tochon","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321502231900_bib23","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.2174\/15672050113109990203","article-title":"isoniazid: an update on the multiple mechanisms for a singular action","volume":"20","author":"Bernardes-G\u00e9nisson","year":"2013","journal-title":"Curr Med Chem"},{"key":"2026030321502231900_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/icb.1962.23","article-title":"The influence of copper on the uptake of hydrazides","volume":"40","author":"Youatt","year":"1962","journal-title":"Aust J Exp Biol"},{"key":"2026030321502231900_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2016.02.003","article-title":"Metabolism of isoniazid by neutrophil myeloperoxidase leads to INH-NAD+ adduct formation: a comparison of the reactivity of isoniazid with its known human metabolites","volume":"106","author":"Khan","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"2026030321502231900_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2019.03.019","article-title":"Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD+","volume":"305","author":"Babu","year":"2019","journal-title":"Chem Biol Interact"},{"key":"2026030321502231900_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/AAC.05486-11","article-title":"A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct","volume":"56","author":"Mahapatra","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030321502231900_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tim.2006.05.006","article-title":"Control of iron metabolism in Mycobacterium tuberculosis","volume":"14","author":"Rodriguez","year":"2006","journal-title":"Trends Microbiol"},{"key":"2026030321502231900_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tube.2003.08.012","article-title":"Iron, mycobacteria and tuberculosis","volume":"84","author":"Ratledge","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"2026030321502231900_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.chom.2011.08.006","article-title":"Mycobacterial p(1)-type ATPases mediate resistance to zinc poisoning in human macrophages","volume":"10","author":"Botella","year":"2011","journal-title":"Cell Host Microbe"},{"key":"2026030321502231900_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3156.2010.02665.x","article-title":"Viewpoint: scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection","volume":"16","author":"Zumla","year":"2011","journal-title":"Trop Med Int Health"},{"key":"2026030321502231900_bib32","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1111\/bph.14867","article-title":"Isoniazid and host immune system interactions: a proposal for a novel comprehensive mode of action","volume":"176","author":"Khan","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2026030321502231900_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2015.11.026","article-title":"Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells","volume":"244","author":"Khan","year":"2016","journal-title":"Chem Biol Interact"},{"key":"2026030321502231900_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.abb.2019.01.004","article-title":"Isoniazid induces a monocytic-like phenotype in HL-60 cells","volume":"664","author":"Babu","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"2026030321502231900_bib35","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazb\u00f3n","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/8\/1159\/67176491\/ajrccm_202_8_1159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/8\/1159\/67176491\/ajrccm_202_8_1159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:50:30Z","timestamp":1772592630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/8\/1159\/8495388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201908-1576oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"2019-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}